Founded in 2001, Eddingpharm is a fast growing Chinese specialty pharmaceutical company, committed to bringing to the Chinese healthcare market high quality medicines from all over the world, providing patients with more treatment options and better opportunities for recovery. We promote the communication and collaboration between Chinese clinical experts and leading international medical research institutes, and provide academic support to Chinese clinical doctors.

Eddingpharm takes an academic-focused promoting and marketing approach. The Company has a strong footprint in top tier cities – the core healthcare market in China – and is growing rapidly in lower tier cities. Eddingpharm’s wide and expanding coverage included more than 17,000 hospitals and clinics,more than 15,000 pharmacies in 30 provinces at the end of Augest, 2017. Over 1,200 professional sales personnel work for Eddingpharm, most of which have pharmaceutical-related backgrounds.

The company focuses on developing and promoting products in four therapeutic areas: clinical nutrition, antibiotics, respiratory system, nephrology and cardiovascular. The Company expands its portfolio through product in-licensing, joint venture, strategic alliance, exclusive distribution, and other forms of collaboration with multinational pharmaceutical companies, specialty pharmaceutical companies, and biotech companies in the US and Europe.

The headquarters of Eddingpharm is located in Hong Kong and the branch office can be found in Beijing, Guangzhou and Chengdu. Its operation center is Shanghai while the import and export trade and logistics center is in Macau and Taizhou.

Eddingpharm has grown into an organization with near 1,500 employees in China, including an experienced product registration and clinical trial management team.